Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R T Dorr

Showing results (41-50 of 156) with videos related to

Pageof 16
Sort By:
Immunopharmacology|July 1, 1989
Effect of interferon, interleukin-2 and tumor necrosis factor on myocardial cell viability and doxorubicin cardiotoxicity in vitroR T Dorr, N G Shipp
Arizona Medicine|August 1, 1983
Choosing a sunscreenM V Relling, R T Dorr
Oncology Nursing Forum|May 1, 1991
Case report: topical DMSO for mitomycin-C-induced skin ulcerationD S Alberts, R T Dorr
Cancer Treatment Reviews|September 8, 2001
Drug interactions with the taxanes: clinical implicationsA F Baker, R T Dorr
European Journal of Cancer (Oxford, England : 1990)|January 1, 1996
Cardioprotection of rat heart myocytes with amifostine (Ethyol) and its free thiol, WR-1065, in vitroR T Dorr, K Lagel, S McLean
PDA Journal of Pharmaceutical Science and Technology|August 6, 2000
Approaches to reducing toxicity of parenteral anticancer drug formulations using cyclodextrinsR Bhardwaj, R T Dorr, J Blanchard
Journal of Medicinal Chemistry|October 19, 2001
Aziridinyl quinone antitumor agents based on indoles and cyclopent[b]indoles: structure-activity relationships for cytotoxicity and antitumor activityE B Skibo, C Xing, R T Dorr
Cancer|July 1, 1996
Skin ulceration potential of paclitaxel in a mouse skin model in vivoR T Dorr, K Snead, J D Liddil
Cancer Chemotherapy and Pharmacology|January 1, 1986
Lack of experimental vesicant activity for the anticancer agents cisplatin, melphalan, and mitoxantroneR T Dorr, D S Alberts, M Soble
Cancer Chemotherapy and Pharmacology|January 1, 1988
Efficacy of sodium thiosulfate as a local antidote to mechlorethamine skin toxicity in the mouseR T Dorr, M Soble, D S Alberts
Pageof 16

Showing results (41-50 of 156) with videos related to

Sort By:
Pageof 16
Immunopharmacology|July 1, 1989
Effect of interferon, interleukin-2 and tumor necrosis factor on myocardial cell viability and doxorubicin cardiotoxicity in vitroR T Dorr, N G Shipp
Arizona Medicine|August 1, 1983
Choosing a sunscreenM V Relling, R T Dorr
Oncology Nursing Forum|May 1, 1991
Case report: topical DMSO for mitomycin-C-induced skin ulcerationD S Alberts, R T Dorr
Cancer Treatment Reviews|September 8, 2001
Drug interactions with the taxanes: clinical implicationsA F Baker, R T Dorr
European Journal of Cancer (Oxford, England : 1990)|January 1, 1996
Cardioprotection of rat heart myocytes with amifostine (Ethyol) and its free thiol, WR-1065, in vitroR T Dorr, K Lagel, S McLean
PDA Journal of Pharmaceutical Science and Technology|August 6, 2000
Approaches to reducing toxicity of parenteral anticancer drug formulations using cyclodextrinsR Bhardwaj, R T Dorr, J Blanchard
Journal of Medicinal Chemistry|October 19, 2001
Aziridinyl quinone antitumor agents based on indoles and cyclopent[b]indoles: structure-activity relationships for cytotoxicity and antitumor activityE B Skibo, C Xing, R T Dorr
Cancer|July 1, 1996
Skin ulceration potential of paclitaxel in a mouse skin model in vivoR T Dorr, K Snead, J D Liddil
Cancer Chemotherapy and Pharmacology|January 1, 1986
Lack of experimental vesicant activity for the anticancer agents cisplatin, melphalan, and mitoxantroneR T Dorr, D S Alberts, M Soble
Cancer Chemotherapy and Pharmacology|January 1, 1988
Efficacy of sodium thiosulfate as a local antidote to mechlorethamine skin toxicity in the mouseR T Dorr, M Soble, D S Alberts
Pageof 16